ホーム › 非小細胞肺癌 › カリフォルニア州 › Newport Beach
Newport Beach、CAにおける非小細胞肺癌の臨床試験
Newport Beachとその周辺地域（約30マイル以内）の拠点で、非小細胞肺癌に関する14件の研究が参加者を募集しています。研究を開いて、参加資格と連絡方法を確認してください。
公式研究テキスト（英語）
ここで研究参加者を募集していますか？ このページの上部に表示できます — 30日間 $99 →
Neladalkib (NVL-655) for TKI-naive Patients With Advanced ALK-Positive NSCLC
被験者募集中第3相
- Hoag Hospital Newport Beach, Newport Beach
A Study of NT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation
被験者募集中第1相
- Research Site, Newport Beach
A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019)
被験者募集中第3相
- Hoag Memorial Hospital Presbyterian ( Site 0096), Newport Beach
Phase 1 Study to Investigate TCRTs KRAS Mutation in Unresectable, Advanced, and/or Metastatic Solid Tumors
被験者募集中第1相
- Research Site, Newport Beach
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
被験者募集中観察研究
- Hoag Memorial Hospital Presbyterian, Newport Beach
A Study of KK2269 in Adult Participants With Solid Tumors
被験者募集中第1相
- Hoag Memorial Hospital Presbyterian, Newport Beach
A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
被験者募集中第3相
- Hoag Memorial Hospital, Newport Beach
A Phase 1 Study of LNCB74 in Advanced Solid Tumors
被験者募集中第1相
- Hoag Family Cancer Institute, Newport Beach
Blood-brain Barrier (BBB) Opening Using Exablate Focused Ultrasound With Standard of Care Treatment of NSCLC Brain Mets
被験者募集中第3相
- Hoag Memorial Hospital Presbyterian, Newport Beach
A Study of BMS-986340 as Monotherapy and as Combination Therapy in Participants With Advanced Solid Tumors
被験者募集中第1/2相
- Hoag Memorial Hospital Presbyterian, Newport Beach
Study of STK-012 Alone and With Other Treatments in Patients With Advanced Lung Cancer and Other Cancers
被験者募集中第1/2相
- Hoag Memorial Hospital Presbyterian, Newport Beach
LUNAR-2: TTFields With Pembrolizumab + Platinum-based Chemotherapy for Metastatic NSCLC
被験者募集中第3相
- Hoag Family Cancer Institute - Hoag Memorial Hospital, Newport Beach
Immunotherapy Biomarkers to Predict First-line PD(L)1-based Immunotherapy Response and Selection of Second-line Treatment in Stage IIIB-IV Non-small Cell Lung Cancer, IMMUNO-BIOMAP Trial
被験者募集中第2相
- City of Hope at Newport Beach Fashion Island, Newport Beach
A Phase 1 Study of CPO301 in Adult Patients With Advanced or Metastatic Solid Tumors
被験者募集中第1相
- Hoag Memorial Hospital Presbyterian, Newport Beach
他の都市における非小細胞肺癌の試験
- Houston, TX145件の研究
- New York City, NY121件の研究
- Arlington, VA104件の研究
- Nashville, TN97件の研究
- Boston, MA90件の研究
- Los Angeles, CA87件の研究
- St. Louis, MO73件の研究
- Chicago, IL61件の研究
- Baltimore, MD60件の研究
- San Antonio, TX59件の研究
- Columbus, OH57件の研究
- Washington, DC55件の研究
Newport Beachにおける他の研究
- 乳がん16件の研究
- 転移性癌10件の研究
- COPD9件の研究
- 卵巣がん9件の研究
- 子宮内膜がん7件の研究
- 肺がん7件の研究
- 大腸癌6件の研究
- 前立腺がん6件の研究
- トリプルネガティブ乳がん6件の研究
- がん（全種類）6件の研究
- 頭頸部扁平上皮癌5件の研究
- 腎臓がん（腎細胞がん）5件の研究
ClinicalTrials.govより、2026/10/06時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。